Facebook Linkedin RSS Twitter Youtube
Home 2023

Astellas

Staying the Course: New CEO, Same Focus for Astellas Gene Therapies
Drug Discovery

Staying the Course: New CEO, Same Focus for Astellas Gene Therapies

StockWatch: Seven Analysts Cut Price Target for Taysha on FDA Advice, Job Cuts
Cancer

StockWatch: Seven Analysts Cut Price Target for Taysha on FDA Advice, Job Cuts

StockWatch: Astellas Hones Gene Therapy Focus with Taysha Stake
Cancer

StockWatch: Astellas Hones Gene Therapy Focus with Taysha Stake

Astellas Raises Gene Therapy Bet with $100M Manufacturing Facility
GEN Edge

Astellas Raises Gene Therapy Bet with $100M Manufacturing Facility

scRNASeq for the Discovery of Malignant Tumor Antigens
Cancer

scRNASeq for the Discovery of Malignant Tumor Antigens

Astellas Weighs Move into Exosomes
GEN Edge

Astellas Weighs Move into Exosomes

Astellas, Dyno Launch Up-to-$1.6B+ Gene Therapy Collaboration
Genome Editing

Astellas, Dyno Launch Up-to-$1.6B+ Gene Therapy Collaboration

Fourth Boy Dies in Trial of Astellas Gene Therapy Candidate
Drug Discovery

Fourth Boy Dies in Trial of Astellas Gene Therapy Candidate

Astellas Takes AIRM Opening New Regenerative Medicine Institute in Massachusetts
Drug Discovery

Astellas Takes AIRM Opening New Regenerative Medicine Institute in Massachusetts

Overcoming Scale-Up Challenges in Gene Therapy Manufacturing
Bioprocessing

Overcoming Scale-Up Challenges in Gene Therapy Manufacturing

123...13Page 2 of 13
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.